In a recent paper from the group of Prof. Lammert, University of Dusseldorf, Germany, in Nature Medicine (Marquardt et al., Nature Medicine 21 (2015) 363–372) extensive investigations on the effect of the NMDA-receptor antagonist dextromethorphan on pancreatic
Nature Medicine: NMDA-Receptor antagonist affects pancreatic islet cells Read More »
MLM has applied for CAP accreditation as a clinical lab in 2014. After a very successful inspection towards the end of 2014 MLM now received the accreditation certificate. The CAP accreditation is an important milestone
MLM has been successfully accredited by the College of American Pathologists Read More »
The year has been very successful and the growth path of the recent years has been further pursued in 2014. The introduction of MLM’s web access mlm online (R) and the establishment and validation of a variety of multiplex-assays
2014 has been a successful year for MLM Read More »
The release of the EMA Reflection paper on GCLP in 2012 clearly helped to define the requirements of the regulatory authorities for laboratories involved in clinical trials. These requirements will be extensively described and discussed by Prof. Dr. Stephan Wnendt
GCLP Training on December 10, 2014, in Tubingen, Germany Read More »
Laboratories involved in the analysis of clinical trial samples have recently received new regulatory guidance from EMA and FDA. The EMA reflection paper for laboratories that perform the analysis of clinical trial samples issued in 2012
MLM to present at the annual meeting of the DGGF in Magdeburg on Sept. 19, 2014 Read More »
Simultaneous assessment of a whole variety of biomarkers is relevant for several topics within clinical trials. Either there is the intention to investigate the pathophysiological processes or to test the efficacy of drug candidates based on biomarkers.
MLM invested in MSD Sector Imager Read More »
By end of March 2014 MLM has been re-certified by the NGSP as a level 1 laboratory for the assessment of HbA1c. This re-certification confirmes that MLM is one out of only two laboratories in Germany that is compliant with the highest quality standards in HbA1c analysis.
NGSP certificate has been successfully renewed Read More »
The draft guideline published by the FDA defines the criteria that have to be fulfilled by analytical methods used for the assessment of drug compounds and their metabolites and of biomarkers.
FDA issued draft guidance on Bioanalytical Method Validation Read More »
‘Choosing the right lab: Big is not always beautiful’ is the title of a paper written by Prof. Dr. Stephan Wnendt and Dr. Katja Neuer published in Journal for Clinical Studies. Thies paper summarizes some criteria for the choice of central
Choosing the right lab for clinical studies Read More »
MLM is holding the DIN EN ISO 15189:2007 accreditation as a medical laboratory since 2003 and was subjected to a re-accreditation inspection by the German accreditation authority, the so-called DAkkS
MLM has successfully been re-accredited according to DIN EN ISO 15189:2007 Read More »
